MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
DNLI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Denali Therapeutics (DNLI) Ownership - Who owns Denali Therapeutics?

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
161 Oyster Point Boulevard
Phone
+1 650 866-8547
Employees
503
Web
https://www.denalitherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.82B
P/E Ratio
N/A
Total Cash
987.68M
Projected Growth
N/A
Total Debt
34.54M
Revenue
N/A
Risk (Beta)
1.58
Dividend Yield
N/A
Total Cash/Share
6.22
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
DNLI
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for DNLI
A.I. Advisor
published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
161 Oyster Point Boulevard
Phone
+1 650 866-8547
Employees
503
Web
https://www.denalitherapeutics.com